Translesion synthesis is an important mechanism in response to unrepaired DNA lesions during replication. The DNA polymerase z (Polz) mutagenesis pathway is a major error-prone translesion synthesis mechanism requiring Polz and Rev1. In addition to its dCMP transferase, a non-catalytic function of Rev1 is suspected in cellular response to certain types of DNA lesions. However, it is not well understood about the non-catalytic function of Rev1 in translesion synthesis. We have analyzed the role of Rev1 in translesion synthesis of an acetylaminouorene (AAF)-dG DNA adduct. Puri®ed yeast Rev1 was essentially unresponsive to a template AAF-dG DNA adduct, in contrast to its ef®cient C insertion opposite a template 1,N 6 -ethenoadenine adduct. Puri®ed yeast Polz was very inef®cient in the bypass of the AAF-dG adduct. Combining Rev1 and Polz, however, led to a synergistic effect on translesion synthesis. Rev1 protein enhanced Polz-catalyzed nucleotide insertion opposite the AAF-dG adduct and strongly stimulated Polz-catalyzed extension from opposite the lesion. Rev1 also stimulated the de®cient synthesis by Polz at the very end of undamaged DNA templates. Deleting the C-terminal 205 aa of Rev1 did not affect its dCMP transferase activity, but abolished its stimulatory activity on Polz-catalyzed extension from opposite the AAF-dG adduct. These results suggest that translesion synthesis of AAF-dG adducts by Polz is stimulated by Rev1 protein in yeast. Consistent with the in vitro results, both Polz and Rev1 were found to be equally important for error-prone translesion synthesis across from AAF-dG DNA adducts in yeast cells.
INTRODUCTION
Translesion synthesis is an important mechanism of damage tolerance in response to unrepaired DNA lesions during replication. Translesion synthesis leads to replication of the damaged regions of the genome. It requires a specialized DNA polymerase (Pol) to directly copy the damaged site on the DNA template. Since DNA damage can change the coding property of the bases, alter DNA structure or render the site non-coding, an incorrect nucleotide is often inserted opposite the lesion during translesion synthesis. This is referred to as error-prone translesion synthesis. It is also possible that the correct nucleotide is inserted opposite the lesion, resulting in error-free translesion synthesis.
The major translesion synthesis polymerases are Polz and the Y family DNA polymerases in eukaryotes. In addition, Polm has also been shown to possess robust translesion synthesis activity in vitro (1, 2) . Whether Polm contributes signi®cantly to translesion synthesis as a damage tolerance mechanism in vivo, however, remains to be determined. In humans, the Y family of DNA polymerases consists of Polh, Poli, Polk and REV1 (3) . In the yeast Saccharomyces cerevisiae, Poli and Polk are not found. Genetic studies in yeast have indicated that Polz (the Rev3±Rev7 complex) operates in a biochemical pathway that involves additional proteins including Rev1 (reviewed in refs 4, 5) , which is also referred to as the Polz mutagenesis pathway. Unlike other members in the Y family of DNA polymerases, Rev1 is a dCMP transferase, rather than a typical DNA polymerase. Rev1 is able to insert a C opposite a template G and several types of DNA lesions, including apurinic/apyrimidinic (AP) site, 8-oxoguanine, (+)-trans-anti-benzo [a] pyrene-N 2 -dG, (±)-trans-anti-benzo [a] pyrene-N 2 -dG and 1,N 6 -ethenoadenine (6± 9). At least in the case of cellular response to AP sites in DNA, the Rev1 dCMP transferase directly participates in nucleotide insertion opposite the lesion during translesion synthesis in vivo (10) .
Error-prone translesion synthesis is largely responsible for DNA damage-induced mutagenesis. In yeast, the vast majority of mutations induced by UV radiation, acetylamino¯uorene (AAF), AP sites and benzo [a] pyrene diol epoxide are generated by the Polz mutagenesis pathway (10±14). The Polz mutagenesis pathway also exists in humans (7,15±17) and is shown to be the major mechanism for UV-and benzo [a] pyrene diol epoxide-induced mutagenesis in cultured human cells (15, 17, 18) . Thus, it appears that the Polz pathway constitutes a major mechanism of error-prone translesion synthesis and DNA damage-induced mutagenesis in eukaryotes. Although Rev1 is required for the Polz mutagenesis pathway, very little is known about the role of Rev1 in the mutagenesis process. The dCMP transferase of Rev1 is unable to respond to a template TT dimer and a template TT (6±4) photoproduct in vitro (6, 8, 10) , two major DNA lesions of UV radiation. Yet Rev1 is required for UV-induced mutagenesis (10, 19, 20) . Thus, it has been proposed that Rev1 may play another non-catalytic function in the Polz mutagenesis pathway (10, 20) . However, it is not well understood about the non-catalytic function of the Rev1 protein in translesion synthesis.
To better understand Rev1 functions, we have analyzed the role of this protein in translesion synthesis of an AAF-dG DNA adduct. Whereas the dCMP transferase of puri®ed yeast Rev1 was essentially unresponsive to a template AAF-dG DNA adduct, this protein strongly stimulated the Polzcatalyzed translesion synthesis of AAF-dG DNA adducts. These results suggest a non-catalytic function of Rev1 in the bypass of AAF-dG adducts. Consistent with the in vitro results, we found that both Polz and Rev1 are equally important for error-prone translesion synthesis across from AAF-dG DNA adducts in yeast cells.
MATERIALS AND METHODS

Materials
A mouse monoclonal antibody against the His 6 tag and the Escherichia coli expression vector pQE80 were purchased from Qiagen (Valencia, CA). The plasmid vector pQE80C was constructed by inserting a 90mer duplex DNA encoding a calmodulin binding peptide (21) into the BamHI site of pQE80. The coding sequence of the duplex DNA is 5¢-GATCCAAGCGACGATGGAAAAAGAATTTCATAGCC-GTCTCAGCAGCCAACCGCTTTAAGAAAATCTCATCC-TCCGGGGCACTTAGATCTA-3¢. The E.coli strain BL21 (DE3 Gold) was obtained from Invitrogen (Carlsbad, CA). Calmodulin af®nity resin was purchased from Stratagene (La Jolla, CA). Alkaline phosphatase conjugated anti-mouse IgG was from Sigma Chemicals (St Louis, MO). All oligonucleotides were synthesized by Operon (Alameda, CA). Yeast Polz (the Rev3±Rev7 complex) and human REV1 were puri®ed to near homogeneity as described previously (8, 22) . N-Acetoxy-N-2-acetylamino¯uorene (AAAF, the activated form of AAF) was obtained from the Midwest Research Institute (Kansas City, MO). A 30mer DNA template containing a site-speci®c AAF-dG adduct was prepared as described previously (23) . Its sequence is 5¢-CCTTCTTCA-TTCGAACATACTTCTTCTTCC-3¢, where the modi®ed guanine is underlined. A 36mer template containing a sitespeci®c tetrahydrofuran (AP site analogue) was synthesized by Operon. Its sequence is 5¢-GAAGGGATCCTTAAGACTX-TAACCGGTCTTCGCGCG-3¢, where X designates the AP site.
Yeast strains
Yeast strains used are BY4741Drad14 (pro®cient in mutagenesis) (MATa his3 leu2 met15 ura3 rad14::HIS3) and its isogenic BY4741Drad14Drev1 (rev1 deletion mutant), and BY4741Drad14Drev3 (rev3 deletion mutant). BY4741 was purchased from ATCC (Manassas, VA). BY4741Drev3 (lacking Polz) was constructed as described previously (14) . BY4741Drev1 (lacking Rev1) was constructed by transforming BY4741 cells with a linearized rev1 deletion plasmid construct. The rev1 deletion clone was con®rmed by a functional assay demonstrating reduced UV-resistance and loss of UV-induced mutagenesis. The rev1 deletion strain was further tested for complementation of UV resistance and UVinduced mutagenesis by a plasmid carrying the wild-type REV1 gene. Finally, the RAD14 gene of BY4741, BY4741Drev1 and BY4741Drev3 was deleted by transforming the respective strains with a rad14 deletion plasmid construct and the rad14 deletion phenotype con®rmed as described previously (14) .
Puri®cation of yeast Rev1
The yeast REV1 gene was obtained by PCR using S.cerevisae DNA as the template and the primers 5¢-GAAGATCTAT-GGGTGAACATGGTGGTCTTG-3¢ and 5¢-ACGCGTCGA-CAGGTATTGTT-GCAATGC-3¢. The 3-kb REV1 DNA fragment was then cloned into the BglII and SalI sites of the vector pQE80C, yielding pQE80C-yREV1. Escherichia coli strain BL21 (DE3 Gold) containing pQE80C-yREV1 was grown at 37°C to an OD 600 of 0.8. Rev1 expression was induced by addition of IPTG to a ®nal concentration of 1 mM and growth for 14 h at 16°C. Cells were collected by centrifugation and resuspended in an extraction buffer containing 50 mM Tris±HCl pH 7.5, 10% sucrose, 20% glycerol, 5 mM b-mercaptoethanol and protease inhibitors (24) . Cells were then homogenized by a sonicator, using four pulses of 30 s each with a 2 min pause on ice between pulses. After centrifugation at 18 000 g for 20 min, the clari®ed sample was loaded onto a 1 ml HiTrap chelating column charged with NiSO 4 (Amersham Pharmacia Biotech, Piscataway, NJ), followed by washing the column sequentially with 15 ml of Ni buffer A (50 mM Tris±HCl pH 7.5, 0.5 M NaCl, 10% glycerol, 5 mM b-mercaptoethanol and protease inhibitors) containing 10 mM imidazole and 25 ml of Ni buffer A containing 35 mM imidazole. Bound proteins were eluted with a linear gradient (25 ml) of 35±500 mM imidazole in Ni buffer A. An equal volume of calmodulin binding buffer (50 mM Tris±HCl pH 8.0, 0.3 M NaCl, 4 mM CaCl 2 and 10 mM b-mercaptoethanol) was added to the pooled Rev1 fractions. After centrifugation at 15 000 g for 20 min, the sample was loaded onto a 2 ml calmodulin af®nity column. The column was washed with 15 ml of the calmodulin column buffer (50 mM Tris±HCl pH 8.0, 0.3 M NaCl and 10 mM b-mercaptoethanol). Finally, the column was eluted with three EGTA step-gradients in calmodulin column buffer containing 1, 2 and 4 mM EGTA, respectively.
To construct the REV1DC gene coding for a truncated Rev1 lacking the C-terminal 205 aa, PCR was performed using the plasmid pQE80C-yREV1 as the template and two primers, 5¢-GAAGATCTATGGGTGAACATGGTGGTCTTG-3¢ and 5¢-ACGCGTCGACTAATAATTTCTTTTCTCGAACTCGTTG. The resulting 2.3 kb DNA fragment was cloned into the BglII and SalI sites of the vector pQE80C, yielding pQE80C-yREV1DC. Expression and puri®cation of the C-terminal truncated Rev1DC (94 kDa) were similarly carried out as described above for the full-length Rev1 protein.
DNA polymerase assays
Identical conditions were used for dCMP transferase assays and DNA polymerase assays. A standard DNA polymerase reaction mixture (10 ml) contained 25 mM KH 2 PO 4 (pH 7.0), 5 mM MgCl 2 , 5 mM dithiothreitol, 100 mg/ml bovine serum albumin, 10% glycerol, 50 mM of dNTPs (dATP, dCTP, dTTP and dGTP individually or together as indicated), 50 fmol of an indicated DNA substrate containing a 32 P-labeled primer, and puri®ed Polz, Rev1 or both as indicated. After incubation at 30°C for 30 min, reactions were terminated with 7 ml of a stop solution (20 mM EDTA, 95% formamide, 0.05% bromophenol blue and 0.05% xylene cyanol). The reaction products were resolved on a 20% denaturing polyacrylamide gel and visualized by autoradiography. DNA synthesis products were quantitated by scanning densitometry using the SigmaGel software (Sigma, St Louis, MO) for analysis.
Preparation of AAF-damaged plasmid DNA
Plasmid pCLU (50 mg) was incubated with 10 mM AAAF in a 500-ml reaction mixture containing 20% ethanol and TE buffer (10 mM Tris±HCl, pH 7.5, 1 mM EDTA) for 3 h in the dark at 37°C. The modi®ed DNA was then puri®ed by 5±20% sucrose gradient centrifugation at 28 000 r.p.m. for 17 h at 4°C in a Beckman SW41Ti rotor. Fractions of 0.5 ml each were collected from the bottom of the gradient and 5-ml aliquots were analyzed by electrophoresis on a 1% agarose gel to locate the DNA. Fractions containing supercoiled DNA were pooled, precipitated in ethanol and dissolved in TE buffer.
In vivo mutagenesis assay in yeast
A plasmid-based mutagenesis assay in yeast cells was performed as we reported recently (14) . Brie¯y, damaged or undamaged plasmid pCLU DNA (2 mg) was transformed into yeast cells. Immediately after transformation, cells were collected by centrifugation (20 s at 5000 r.p.m.) in a microcentrifuge, and resuspended in 1 ml of sterile water. An aliquot of 999 ml cell suspension was plated onto three YNB minimal agar plates lacking leucine but supplemented with 5 mM 5-¯uoroorotic acid (5-FOA), 150 mM methionine and 380 mM uracil to score for colonies containing ura3 mutant pCLU. Another aliquot of 1 ml cell suspension was diluted and plated onto YNB minimal agar plates lacking leucine to score for colonies containing replicated pCLU (plasmid survival). Yeast colonies were counted after incubation at 30°C for 3±4 days. Mutation frequency was calculated by dividing the number of the ura3 mutant colonies by the number of colonies containing replicated pCLU.
RESULTS
The dCMP transferase of puri®ed yeast Rev1 is essentially unresponsive to a template AAF-dG adduct
To understand the role of Rev1 in translesion synthesis of AAF-dG DNA adducts, we ®rst determined whether the dCMP transferase of yeast Rev1 is able to insert a C opposite the lesion in vitro. To avoid potential contamination by yeast proteins, we puri®ed yeast Rev1 from E.coli cells following its expression from a plasmid construct. The Rev1 preparation contained two bands of~120 and 90 kDa, respectively (Fig. 1A) . Western blot analysis using a monoclonal antibody against the N-terminal His 6 tag con®rmed that both bands are yeast Rev1 protein (Fig. 1B) . While the larger band is consistent with the calculated molecular mass of yeast Rev1 (112 kDa), thus representing the full-length protein, the smaller band is probably a C-terminal truncated product of Rev1. The eukaryotic Y family DNA polymerases, including Rev1, are relatively unstable and protein truncation is a common feature among them. To determine whether the truncated Rev1 protein retains activity, we deleted 205 aa from its C-terminus, yielding Rev1DC (94 kDa). Rev1DC was similarly expressed in E.coli and puri®ed (Fig. 1C) , yielding a protein of approximately the size of the~90 kDa band in Figure 1A . As shown in Figure 1D , both Rev1 and Rev1DC preparations were similarly active in dCMP transferase in response to a template AP site. Thus, the C-terminal truncated protein of~90 kDa retains the Rev1 dCMP transferase activity.
To examine the response of yeast Rev1 to an AAF-dG adduct, we annealed a 32 P-labeled 17mer primer to the damaged template with the primer 3¢ end terminating right before the lesion ( Fig. 2A) , and performed standard dCMP transferase assays. As shown in Figure 2A , puri®ed yeast Rev1 was unable to effectively catalyze nucleotide insertion opposite the AAF-dG adduct. In contrast, it ef®ciently inserted The puri®ed yeast Rev1 protein (300 ng) was analyzed by a western blot using a mouse monoclonal antibody against the N-terminal His 6 tag. (C) The puri®ed Rev1DC protein (300 ng) lacking the C-terminal 205 aa of yeast Rev1 was analyzed by 10% SDS±polyacrylamide gel and visualized by staining with Coomassie blue. The identity of the protein band that migrated at the~90 kDa position on the gel was con®rmed by western blot analysis using a mouse monoclonal antibody against the N-terminal His 6 tag. (D) A 5¢-32 P-labeled 17mer primer was annealed to a damaged 36mer template, terminating right before the AP site as shown at the bottom. Then, DNA polymerase assays were performed using 5 or 10 ng of puri®ed yeast Rev1 or Rev1DC protein as indicated. DNA size markers in nucleotides are indicated on the left. X, the AP site. a C opposite a template 1,N 6 -ethenoadenine adduct (Fig. 2B) . These results show that the yeast Rev1 dCMP transferase is essentially unresponsive to a template AAF-dG adduct.
Synergistic effect of Polz and Rev1 combination during bypass of a template AAF-dG adduct in vitro
Since puri®ed yeast Polz alone is inef®cient in performing translesion synthesis across from a template AAF-dG adduct (22), we suspected that accessory factor(s) might be required to stimulate lesion bypass by Polz in vivo. To test whether Rev1 could play such a role, we performed DNA synthesis reactions with the AAF-damaged template by combining puri®ed yeast Polz and Rev1 together. In the reaction, a 13mer 32 P-labeled primer was annealed to the damaged template, terminating 4 nt before the lesion (Fig. 3) . Consistent with our previous ®nding (22) , the AAF-dG adduct strongly blocked DNA synthesis by yeast Polz right before the lesion, as evidenced by the strong 17mer DNA band (Fig. 3, lane 3) . Only very small amounts of the damaged templates were bypassed (longer than 18mer DNA bands), and the 30mer fulllength product or near full-length products were not detected (Fig. 3, lane 3) . When puri®ed yeast Rev1 protein was added to the reaction, much higher levels of the damaged templates were bypassed and the 30mer full-length product was readily detected (Fig. 3, lane 4) . These results show that combination of yeast Polz and Rev1 has a synergistic effect on the bypass of AAF-dG DNA adducts.
We consistently observed that the last template base was inef®ciently copied by Polz even from undamaged templates (22) (Fig. 3, lane 1) . Surprisingly, addition of yeast Rev1 protein greatly stimulated DNA synthesis at the end of the undamaged template (Fig. 3, lane 2) . The 30mer full-length product migrated at the same position in the absence or presence of Rev1 (Fig. 3, compare lanes 1 and 2) . Therefore, the last nucleotide copied at the very end of the template is consistent with Polz-catalyzed G addition, rather than C addition catalyzed by the Rev1 dCMP transferase. C addition would have resulted in a 30mer product that migrated signi®cantly faster than the 30mer DNA band in lane 1 of Figure 3 . These results show that Rev1 stimulates the inef®cient DNA synthesis of Polz at the end of the template. 
Effect of Rev1 on Polz-catalyzed nucleotide insertion opposite a template AAF-dG adduct
Translesion synthesis consists of two distinct steps: nucleotide insertion opposite the lesion and extension DNA synthesis from opposite the lesion. To understand the role of Rev1 in the synergistic bypass by the Rev1±Polz combination, we determined whether Rev1 affects nucleotide insertion by Polz opposite the AAF-dG adduct. Yeast Polz alone inserted 14 fmol C and 12 fmol G opposite the AAF-dG adduct (Fig. 4,  lanes 3 and 4, respectively) . In the presence of puri®ed Rev1 protein, C insertion opposite the lesion was increased to 23 fmol (1.6-fold increase), while G insertion was increased to 18 fmol (1.5-fold increase) (Fig. 4 , compare lanes 3 with 8, and 4 with 9). These results show that while Rev1 stimulates Polz-catalyzed nucleotide insertion opposite the template AAF-dG adduct, it does not alter the speci®city of nucleotide insertion by Polz opposite the lesion.
Effect of Rev1 on Polz-catalyzed extension DNA synthesis from opposite the AAF-dG adduct
To determine whether Rev1 affects extension DNA synthesis from opposite the AAF-dG adduct, we annealed a 32 P-labeled 18mer primer to the damaged template, terminating with an A opposite the lesion (Fig. 5 ). DNA synthesis assays were then performed with puri®ed yeast Polz in the absence or presence of puri®ed yeast Rev1 protein. Rev1 alone was unable to perform extension synthesis from opposite the AAF-dG adduct (Fig. 5A, lane 1) . Polz alone extended the primer only by 1 nt from opposite the AAF-dG adduct, and further extension synthesis was strongly blocked by the lesion (Fig. 5A, lane 2) . In the presence of Rev1 protein, longer extension synthesis by Polz was greatly stimulated (Fig. 5A,  lanes 3±7) . Furthermore, the 30mer full-length extension product was readily detected and its production increased with increasing concentrations of Rev1 in the reaction (Fig. 5A,  lanes 3±7 ). Prior heat inactivation of the Rev1 protein abolished its activation activity (data not shown). Thus, stimulation of Polz-catalyzed extension synthesis depends on a properly folded Rev1 protein. In contrast, the inef®cient extension synthesis by Polh from opposite the AAF-dG adduct was not affected by Rev1 protein (Fig. 5B) . Moreover, human REV1 protein had no effect on extension synthesis by the yeast Polz from opposite the AAF-dG adduct (Fig. 5C) .
High level of stimulation on Polz-catalyzed extension synthesis required relatively high concentrations of the puri®ed Rev1 protein (Fig. 5A) . This raised the possibility that the~90 kDa truncated Rev1 in the protein preparation (Fig. 1A) may not be able to stimulate Polz in extension synthesis. To test this possibility, we performed the extension DNA synthesis assay again using the puri®ed 94 kDa Rev1DC. As shown in Figure 6 (lanes 4±7), even at very high concentrations of the Rev1DC protein, stimulation on Polzcatalyzed extension from opposite the AAF-dG adduct was not observed. Thus, whereas deleting the C-terminal 205 aa of Rev1 does not affect its dCMP transferase, this C-terminal truncation abolishes the stimulating activity of Rev1 on Polz-catalyzed extension from opposite the AAF-dG adduct.
To determine whether or not the Rev1 stimulatory effect on Polz-catalyzed extension synthesis is speci®c to the A-terminated primer, we performed additional assays using four different DNA substrates containing an 18mer primer terminating with a C, A, T or G, respectively, opposite the AAF-dG adduct (Fig. 7) . As shown in Figure 7A±D (compare lane 1 with lane 6), Rev1 stimulated extension synthesis by Polz from opposite the lesion in every case. With or without Rev1, Polz predominantly incorporated the correct G opposite the undamaged template C immediately 5¢ to the lesion ( Figs  6D and 7A, lanes 4 and 9) . Thus, the speci®city of nucleotide incorporation during extension synthesis by Polz from opposite the AAF-dG adduct was not affected by Rev1 protein. These results show that Rev1 protein strongly and speci®cally stimulates Polz-catalyzed extension DNA synthesis from opposite the AAF-dG adduct, and that Rev1 does not alter the Polz speci®city of nucleotide incorporation during extension synthesis.
Both Polz and Rev1 are required for AAF adduct-induced mutagenesis in yeast cells
Since Rev1 is able to strongly stimulate Polz-catalyzed extension synthesis from mismatched primer end opposite the AAF-dG adduct, it is likely that both Polz and Rev1 are critical to AAF-induced mutagenesis in cells. To test this hypothesis, we examined the effect of inactivating Polz and Rev1 on AAF adduct-induced mutagenesis in yeast cells, using a plasmid-based in vivo mutagenesis assay (14) . In this assay, the pCLU plasmid was ®rst damaged by 10 mM AAAF in vitro and puri®ed by centrifugation in a linear 5±20% sucrose gradient. Then, the damaged plasmid was transformed into yeast cells. The plasmid contains the yeast LEU2 gene as the selection marker and the yeast URA3 gene as the mutagenesis target. Transformed cells were plated on leucine-lacking minimal medium plates with or without 5-FOA. Plates without 5-FOA allowed cells that had replicated the damaged pCLU plasmid to grow to colonies, thus measuring replication of the damaged plasmid (plasmid survival'). Plates with 5-FOA allowed only those cells that contained inactivating mutations at the plasmid URA3 gene to grow to colonies, thus measuring mutagenesis of the plasmid URA3 gene. The chromosomal URA3 gene had been deleted from all yeast strains used. Once inside cells, AAF adducts on the plasmid DNA are subject to removal by nucleotide excision repair (25±27). In order to effectively detect induced mutagenesis at a relatively low AAAF concentration, we inactivated the nucleotide excision repair pathway by deleting the RAD14 gene from yeast strains used in this study.
Untreated pCLU plasmid DNA was used in the assay as the control for spontaneous mutagenesis. In cells pro®cient in mutagenesis (rad14), a spontaneous mutation frequency of 3.2 Q 14 ±4 was obtained (Table 1) . A similar spontaneous mutation frequency was observed with cells lacking Rev1 (rad14 rev1) ( Table 1 ). In cells lacking Polz (rad14 rev3), the spontaneous mutation frequency was slightly increased (Table 1) . After treatment of the plasmid DNA with 10 mM AAAF, the induced mutation frequency of the plasmid URA3 gene was increased by 10-fold, as compared with the spontaneous mutation frequency (Table 1) . Without Rev1 or Polz, AAF adduct-induced mutation was largely abolished to levels of only 2.1-and 1.6-fold above the spontaneous mutation frequency, respectively (Table 1 ). These results show that both Polz and Rev1 are required for AAF adductinduced mutagenesis in yeast cells. Since the induced mutation frequencies in cells lacking Rev1 or Polz were reduced to similar levels of 8.2 Q 14 ±4 and 8.9 Q 14 ±4 , 
DISCUSSION
In yeast cells, Polz is clearly required for error-prone translesion synthesis across from AAF-dG DNA adducts (12, 13) . However, the puri®ed yeast Polz is rather inef®cient in performing translesion synthesis across from a template AAF-dG adduct (22) . Thus, effective bypass of AAF-dG adducts in cells may require accessory factor(s). Supporting this notion, much more ef®cient bypass of the AAF-dG adduct was achieved by combining puri®ed yeast Polz and Rev1. Rev1 alone is unable to catalyze either nucleotide insertion opposite the AAF-dG adduct or extension synthesis from opposite this lesion. Furthermore, the Rev1 C-terminal truncation of 205 aa abolished its stimulatory activity but retained its dCMP transferase activity. Therefore, Rev1 most likely plays a non-catalytic function by stimulating the Polzcatalyzed translesion synthesis across from the lesion. Indeed, both the Polz-catalyzed nucleotide insertion step and the extension synthesis step were stimulated by Rev1. Further supporting its non-catalytic role, Rev1 did not alter the Polz speci®city of nucleotide incorporation at both the nucleotide insertion and extension synthesis steps. If the dCMP transferase activity of Rev1 were involved in synergistic bypass by the Rev1±Polz combination, C incorporation during nucleotide insertion opposite the AAF-dG adduct and extension from opposite the lesion would have been signi®cantly elevated. This was not the case. However, whether the dCMP transferase active site is required for the stimulatory function of Rev1 on Polz remains to be determined. If the stimulatory function of Rev1 is important in vivo, mutagenesis induced by AAF-dG DNA adducts in yeast cells would depend on both the Rev1 and Polz proteins. This was shown to be the case. Without Polz or Rev1, AAF-induced mutagenesis was reduced by~4-fold in yeast cells. Hence, Rev1 is equally important as Polz for error-prone translesion synthesis across from AAF-dG DNA adducts in vivo. Missing either Rev1 or Polz will inactivate the major mechanism of error-prone translesion synthesis, thus, underscoring the importance of the functional interaction between these two polymerases in response to AAF-DNA adducts. Using a plasmid containing a site-speci®c AAF-dG adduct, Baynton et al. (13) also observed that Rev1 is required for non-slipped translesion synthesis at the two sequence contexts, 5¢-GGG AAF -3¢ and 5¢-GGCG AAF CC-3¢, in yeast cells.
Recently, it has been observed that multiple DNA polymerases are involved in translesion synthesis of TT (6± 4) photoproducts, AAF-dG adducts and benzo[a]pyrene diol epoxide in cells (14, 28, 29) . However, it is not clear how such a multiple-polymerase mode of translesion synthesis takes place in cells. Are these polymerases recruited to the lesion site simultaneously, cooperatively or independently? Does the in vivo lesion bypass re¯ect a two-polymerase two-step mechanism (8, 22, 30, 31) ? Are there functional interactions among Polz and the Y family DNA polymerases? Our studies suggest that there exists a functional interaction between two DNA polymerases for translesion synthesis. Thus, functional interactions between two polymerases may represent an important feature for translesion synthesis during cellular response to certain types of DNA lesions.
The precise mechanism of the functional interaction between Rev1 and Polz is unknown at the present time. One possibility is that Rev1 may somehow facilitate the binding of Polz to its DNA substrate and/or decrease the dissociation of Polz from the DNA template. Consistent with such a mechanism, Rev1 also strongly stimulated the de®cient synthesis by Polz at the very end of undamaged DNA templates. Since human REV1 could not substitute for the yeast Rev1 for its stimulatory activity on the yeast Polz, the Rev1 effect could not have simply resulted from the Rev1± DNA interaction. It is not surprising that human Rev1 could not stimulate yeast Polz, because even the four most conserved regions of the two proteins share only 21±35% sequence identity and 43±59% sequence similarity (7). More likely, the functional interaction between Rev1 and Polz during synergistic bypass of the AAF-dG DNA adducts may be mediated by physical interactions between them. Physical interaction between human REV1 and human REV7, the noncatalytic subunit of Polz, has indeed been observed (32) . Whether the yeast Rev1 similarly interacts with the yeast Rev7, however, remains to be determined.
Although Rev1 acts as a DNA polymerase on repeating template G sequences and has therefore been suggested as a specialized DNA polymerase (8, 9) , its dCMP transferase activity is remarkable. With respect to its catalytic function, Rev1 recognizes various damaged and undamaged template bases with very different af®nity, but it preferentially inserts dCMP without an exception (6, 8, 9, 33) . Hence, the rules of geometry constraints and hydrogen bonding that governs nucleotide selection during normal DNA synthesis simply do not apply to Rev1. The structural basis for the unique C insertion opposite the various undamaged and damaged template bases is a mystery. Clues about the structural basis of the Rev1 dCMP transferase activity would have to wait for the crystal structural studies of the protein. Like its human counterpart, yeast Rev1 also ef®ciently inserts a C opposite a template 1,N 6 -ethenoadenine adduct. The essentially unresponsiveness of human REV1 to a template AAF-dG adduct was also observed with the yeast Rev1. Thus, although the protein sequences of yeast Rev1 and human REV1 are not overwhelmingly conserved, their biochemical properties appear to be highly conserved. So far, direct participation of the Rev1 dCMP transferase activity at the nucleotide insertion step has been demonstrated in only one case in cells: translesion synthesis of AP sites (10) . It is of great interest to determine in the future whether such an involvement of the Rev1 dCMP transferase is only limited to cellular response to AP sites or constitutes a more general mechanism in the Polz mutagenesis pathway. Regardless of the extent to which the catalytic dCMP transferase function is employed during in vivo translesion synthesis of various types of DNA lesions, a noncatalytic role appears to be an important and may well be the predominant function of Rev1 in the Polz mutagenesis pathway. Our studies suggest one such non-catalytic function for Rev1 in the translesion synthesis of AAF-dG DNA adducts. Extended studies into other types of DNA lesions could bring in more insights into our understanding of this fascinating member of the Y family DNA polymerases in translesion synthesis.
